Zdrowie i gospodarka · 06/01/1999
FDA Withdraws Approval of Dipyridamole Drugs Due to Lack of Evidence
The FDA is withdrawing conditional approval of certain dipyridamole drug products and declaring three unapproved products unlawful, citing insufficient evidence of their effectiveness in treating chronic angina pectoris.